Could GLP-1 drugs finally put a price on crop nutrient density?
With the rise of GLP-1 drugs, food companies may begin to compete on a ‘nutrition per calorie’ basis, predicts a new report.
With the rise of GLP-1 drugs, food companies may begin to compete on a ‘nutrition per calorie’ basis, predicts a new report.
Twiga’s administration does not signal the death of B2B food distribution in East Africa, but a changing of the guard.
New capital will help Myca widen its geographical footprint across Southeast Asia, Latin America, Africa and India.